265 related articles for article (PubMed ID: 21614909)
21. Does the presence of adenomyosis and lymphovascular space invasion affect lymph node status in patients with endometrioid adenocarcinoma of the endometrium?
Musa F; Frey MK; Im HB; Chekmareva M; Ellenson LH; Holcomb K
Am J Obstet Gynecol; 2012 Nov; 207(5):417.e1-6. PubMed ID: 22840974
[TBL] [Abstract][Full Text] [Related]
22. Very early stage adenocarcinoma arising from adenomyosis in the uterus.
Hsu MI; Chou SY; Lin SE; Liang SJ; Chiu HC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):346-9. PubMed ID: 17175497
[TBL] [Abstract][Full Text] [Related]
23. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
[TBL] [Abstract][Full Text] [Related]
24. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
25. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
26. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
[TBL] [Abstract][Full Text] [Related]
27. P53 expression in adenomyosis in endometrial carcinoma patients.
Taskin M; Lallas TA; Shevchuk M; Barber HR
Gynecol Oncol; 1996 Aug; 62(2):241-6. PubMed ID: 8751556
[TBL] [Abstract][Full Text] [Related]
28. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
29. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
Hanley KZ; Dustin SM; Stoler MH; Atkins KA
Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
[TBL] [Abstract][Full Text] [Related]
30. Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report.
Wang J; Wang Q; Wang W; Yang J; Xia J; Wei Y
BMC Womens Health; 2023 Mar; 23(1):150. PubMed ID: 36997927
[TBL] [Abstract][Full Text] [Related]
31. Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report.
Puppa G; Shozu M; Perin T; Nomura K; Gloghini A; Campagnutta E; Canzonieri V
BMC Cancer; 2007 Jun; 7():103. PubMed ID: 17584489
[TBL] [Abstract][Full Text] [Related]
32. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
[TBL] [Abstract][Full Text] [Related]
33. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
34. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
36. Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
[TBL] [Abstract][Full Text] [Related]
37. Correlation between preoperative endometrial sampling and final endometrial cancer histology.
Sany O; Singh K; Jha S
Eur J Gynaecol Oncol; 2012; 33(2):142-4. PubMed ID: 22611951
[TBL] [Abstract][Full Text] [Related]
38. Well differentiated endometrioid adenocarcinoma of the uterus: a cancer unit or centre case?
Montalto SA; Hakmi A; Moth P; Raju KS; Coutts M; Papadopoulos AJ; Devaja O
Eur J Gynaecol Oncol; 2009; 30(1):35-9. PubMed ID: 19317254
[TBL] [Abstract][Full Text] [Related]
39. [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].
Kommoss F; Lax SF
Pathologe; 2016 Nov; 37(6):512-520. PubMed ID: 27681950
[TBL] [Abstract][Full Text] [Related]
40. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
Jacques SM; Lawrence WD
Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]